<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00707369</url>
  </required_header>
  <id_info>
    <org_study_id>EH 365/1-1</org_study_id>
    <secondary_id>DFG grant: EH 365/1-1</secondary_id>
    <secondary_id>ISRCTN : 64254080</secondary_id>
    <nct_id>NCT00707369</nct_id>
  </id_info>
  <brief_title>Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization</brief_title>
  <acronym>ABPARO-Studie</acronym>
  <official_title>Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the size of the benefit of an adjunctive empiric
      antibiotic therapy compared to standard mechanical debridement and oral hygiene instructions
      in a representative sample of German periodontitis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodontitis is an endemic inflammatory disease caused by a mixed bacterial biofilm
      infection that is followed by destruction of tooth supporting tissues. Standard of care
      consists of lifelong mechanical removal of the biofilm. However, outcome is variable.
      According to recent EFP and AAP reviews, adjunctive antimicrobial therapy may be beneficial.
      We plan to conduct a double-blind, parallel group, randomized, placebo-controlled
      multi-center efficacy study that addresses the following objectives:

        1. What is the size of the benefit of an adjunctive empiric antibiotic therapy compared to
           standard mechanical debridement and oral hygiene instructions in a representative sample
           of German periodontitis patients?

        2. Does the administration of the antibiotic therapy delay recurrence of periodontitis in
           the general population and in specific high risk groups (e.g. smokers) under standard
           supportive therapy?

        3. Is the presence of specific microbial complexes a useful predictor of outcome and
           recurrence of periodontitis?

        4. Does the administration of the antibiotic therapy affect the &quot;oral health related
           quality of life&quot;?

      The primary hypothesis tested is: the administered empiric adjunctive antibiotic therapy
      reduces about one half of the proportion of sites with attachment loss compared to
      subgingival debridement alone over a 27.5-month period in a statistical and clinical
      significant manner.

      To test this hypothesis about 500 patients will be enrolled in the clinical trial. According
      to the intention-to-treat principle, the primary efficacy analysis will include all
      randomized subjects. In addition, a per-protocol analysis will be done.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of sites showing attachment loss ≥ 1.3 mm over a 27.5-months period</measure>
    <time_frame>27.5-months period (six measurements)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective perception of treatment outcome, attachment gain, pocket probing depths, bleeding on probing, and full mouth plaque score. Microbial colonization dynamic.</measure>
    <time_frame>over a 27.5-months period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">540</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mechanical debridement plus 500 mg amoxicillin and 400 mg metronidazole three times daily for 7 days. Supportive periodontal therapy in 3-month intervals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mechanical debridement plus two placebo tablets three times daily for 7 days. Supportive periodontal therapy in 3-month intervals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin and Metronidazole</intervention_name>
    <description>tablets: Amoxicillin 3H2O 574 mg and 400 mg metronidazole three times daily for 7 days</description>
    <arm_group_label>test</arm_group_label>
    <other_name>Flagyl® 400 Filmtablette</other_name>
    <other_name>Amoxicillin-ratiopharm® 500</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets (cellulose powder, lactose monohydrate, magnesium stearate, microcrystalline cellulose): three times daily for 7 days</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  periodontal screening index (PSI) of IV in at least one sextant;

          -  range from 18 to 75 years of age;

          -  clinical and radiographic signs of moderate (clinical attachment loss [CAL] of 3 to 4
             mm) to severe (CAL 5 mm or more) chronic or aggressive periodontitis;

          -  at least 10 natural teeth in situ;

          -  pocket probing depths (PPDs) of ≥ 6 mm at a minimum of four teeth;

          -  willingness to participate and to be available at all times required for
             participation;

          -  willingness to abstain from using antimicrobial mouth-rinses during the study except
             for those explicitly prescribed;

          -  informed consent signed by the patient;

          -  sufficient knowledge of German language.

        Exclusion Criteria:

          -  if they (or parents or siblings) show confirmed or assumed allergies or
             hyper-sensitive skin reactions against amoxicillin (or other penicillins or other
             ingredients of Amoxicillin-ratiopharm® 500mg as listed in the &quot;summary of product
             characteristics, Version Juli 2005&quot;), metronidazole (or other 5-nitroimidazoles and
             ingredients of Flagyl® 400mg as listed in the &quot;summary of product characteristics,
             Version Juli 2007&quot;), systemic diseases or conditions as listed in the above mentioned
             &quot;summary of product characteristics&quot;, or show confirmed lactose intolerance;

          -  have Down's syndrome;

          -  known AIDS/HIV;

          -  regularly take systemic medication affecting the periodontal conditions, e.g.
             phenytoin, nifedipine, and/or steroid drugs;

          -  professional periodontal therapy during 6 months prior to baseline;

          -  require antibiotic treatment for dental appointments;

          -  are undergoing or require extensive dental or orthodontic treatment;

          -  are pregnant or breastfeeding;

          -  have rampant caries;

          -  any oral or extraoral piercing in or around the oral cavity with ornaments or
             accessory jewelry;

          -  are dental students or dental professionals;

          -  have participated in a clinical dental trial in the six months preceding the study;

          -  cognitive deficits.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin - Ehmke, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Muenster, Dept. of Periodontology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Fakultät der Humboldt Universität Berlin (Charité)</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus, Zentrum für Zahn-, Mund- und Kieferheilkunde</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum der Zahn-, Mund- und Kieferheilkunde (Carolinum), Poliklinik für Parodontologie</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Justus-Liebig-Universität Gießen, Poliklinik für Parodontologie</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Greifswald, Poliklinik für Zahnerhaltung, Parodontologie und Kinderzahnheilkunde</name>
      <address>
        <city>Greifswald</city>
        <zip>17487</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg, Poliklinik für Zahnerhaltungskunde, Sektion Parodontologie</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Muenster, Dept. of Periodontology</name>
      <address>
        <city>Muenster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Würzburg, Poliklinik für Parodontologie</name>
      <address>
        <city>Würzburg</city>
        <zip>97070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2008</study_first_submitted>
  <study_first_submitted_qc>June 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2008</study_first_posted>
  <last_update_submitted>March 2, 2015</last_update_submitted>
  <last_update_submitted_qc>March 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Muenster</investigator_affiliation>
    <investigator_full_name>Benjamin Ehmke</investigator_full_name>
    <investigator_title>Prof. Dr. med. dent.</investigator_title>
  </responsible_party>
  <keyword>Periodontitis</keyword>
  <keyword>Mechanical Debridement</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>Attachment loss</keyword>
  <keyword>Randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

